Genetically Engineered Cytomembrane Nanovaccines for Cancer Immunotherapy.
Pan Y, Wu X, Liu L, Zhao C, Zhang J, Yang S, Pan P, Huang Q, Zhao XZ, Tian R, Rao L.
Pan Y, et al. Among authors: zhao xz.
Adv Healthc Mater. 2024 Feb 6:e2400068. doi: 10.1002/adhm.202400068. Online ahead of print.
Adv Healthc Mater. 2024.
PMID: 38320299